Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: A combined analysis of the PROTECHT and TOPIC-2 studies

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 7, 2010, Pages 1649-1651

  Verso, M ^a   Gussoni, G ^b   Agnelli, G ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b FADOI Foundation Research Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CERTOPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; HUMAN; LETTER; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ANTINEOPLASTIC AGENTS; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; LUNG NEOPLASMS; PREMEDICATION; VENOUS THROMBOEMBOLISM;

EID: 77955028825     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03901.x     Document Type: Letter

References (7)

1. Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 2006, 24:484-90.
2. Behrendt CE, Ruiz RB. Venous thromboembolism among patients with advanced lung cancer randomized to prinomastat or placebo, plus chemotherapy. Thromb Haemost 2003, 90:734-7.
3. Tesselaar ME, Osanto S. Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med 2007, 13:362-7.
4. Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005, 293:715-22.
5. Chew HK, Davies AM, Wun T, Harvey D, Zhou H, White RH. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 2008, 6:601-8.
6. Agnelli G, Gussoni G, Bianchini C, Verso M, Mandalà M, Cavanna L, Barni S, Labianca R, Buzzi F, Scambia G, Passalacqua R, Ricci S, Gasparini G, Lorusso V, Bonizzoni E, Tonato M. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol 2009, 10:943-9.
7. Haas S. Prevention of venous thromboembolism with low-molecular-weight heparin in patients with metastatic breast or lung cancer. Results of the TOPIC studies. J Thromb Haemost 2005, 3(suppl 1). abstract OR059